CLS Americas received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG Thermal Therapy System accessories.
The National Institutes of Health (NIH) researchers have discovered a specific network of proteins that is necessary to restore hearing in zebrafish through cell regeneration. The study, led by investigators at the National Human Genome Research Institute (NHGRI), may inform the development of treatments for hearing loss in humans. The findings were published in Cell Genomics.
BOSTON, July 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and with longer-lasting effects.
SAN FRANCISCO--(BUSINESS WIRE)--VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, announced today it has been awarded a $312,310 grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to fund AI-driven development of medications for substance use disorder (SUD). VeriSIM and UF Scripps Biomedical Research scientist Courtney Miller, Ph.D. will collaborate on the research and drug discovery project. Research reported in this announcement was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number 1R43DA056084-01.
NIH starts study of COVID-19 booster shot in people with autoimmune diseases
The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen. The trial also will investigate whether pausing immunosuppressive therapy for autoimmune disease improves the antibody response to an extra dose of a COVID-19 vaccine in this population. The Phase 2 trial is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, and is being conducted by the NIAID-funded Autoimmunity Centers of Excellence.
A newly awarded grant from the National Institutes of Health is the cherry on top of an already groundbreaking year for Synchron, which received the go-ahead from the FDA to begin the first U.S. trial of its brain-computer interface technology last month, mere weeks after reeling in $40 million to fund the study.
One dose of a new monoclonal antibody developed at the US National Institutes of Health (NIH) safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored clinical trial is the first to demonstrate that a monoclonal antibody can prevent malaria in people.
Aug 11 (Reuters) - An experimental monoclonal antibody developed at the U.S. National Institutes of Health (NIH) prevented malaria for up to nine months in volunteers exposed to the disease-causing parasite in a small trial, researchers reported on Wednesday in the New England Journal of Medicine.
The U.S. National Institutes of Health (NIH) said on Tuesday it had launched a new study to assess how patients on immunosuppressive therapy after kidney transplant, who did not respond to the first two doses of COVID-19 vaccine, respond to a third dose.